Laboratory information system software: Trace Orders, Specimens, and Reviewed Results

Laboratory information system software connects test orders, patient and specimen identity, laboratory work, and result reporting. For a clinical lab, the system must preserve the link between the requested test, the material received, and the reviewed result. A missing or unclear link can create more work than a slow screen.

This article explains the core LIS workflow, the distinction from LIMS, and the checks to use in a vendor demo. It also covers analyzer interfaces, amended reports, downtime, access, and a practical rollout plan.

LIS and LIMS: start with the work, not the label

A clinical LIS often centers on patients, orders, specimens, and diagnostic results. A laboratory information management system, or LIMS, often centers on samples, tests, and broader laboratory processes. Product scope can overlap.

Therefore, do not assume the label proves a fit. A clinical chemistry lab, pathology service, research lab, and materials testing business can need very different records and approvals.

Anomoz’s article on laboratory information management explores the wider LIMS category. This guide focuses on the clinical order-to-result path.

Start by listing your disciplines, sites, test catalog, analyzers, ordering systems, and reporting routes. Include referral testing and any manual work. These details provide a better shortlist than a generic feature count.

Patient and order identity come first

The system needs a reliable way to identify the patient and the requested work. Names alone are not enough for a safe matching process. Use the identifiers and checks approved by the organization.

Next, distinguish the patient, encounter, order, specimen, and result records. One patient can have many orders, and an order can involve several specimens. A single generic record can hide those relationships.

Test an uncertain match and a demographic correction. The system should route the issue for review and preserve the history. It should not silently merge records because a few fields look similar.

Also define who may cancel or change an order. A change after collection may require different handling from a draft edit. Keep the stage and consequences visible to staff.

Build a controlled test catalog

The catalog links the requested test with specimen needs, methods, units, reporting rules, and relevant workflow. Each important field needs an owner. A change can affect orders, analyzer mapping, or final reports.

For example, a panel may contain several component tests. The system should show how those results relate without treating every component as an unrelated order.

Next, preserve effective versions where needed. If a method or reporting rule changes, historical results should retain the context that applied at the time. Updating a master field should not rewrite an old report.

Keep local codes and external mappings clear. A shared label does not guarantee that two tests mean the same thing. Have the responsible laboratory team review mappings before exchange.

Track specimens and aliquots through the process

A specimen record should show its identity, collection information, receipt, and relevant status. The exact fields depend on the lab’s approved procedures. The software should make required information clear at the point of work.

Next, test labels and scanning in the actual environment. A code that reads well at a desk may not suit a small container or cold storage. Include the devices and materials staff will use.

If the lab creates aliquots, preserve the parent-child relationship. A result from a derived container should still trace to the original specimen and order. Avoid relying on a handwritten note to maintain that link.

Also keep rejected or unsuitable specimens distinct from accepted work. Record the reason and approved next action. A generic completed status should not imply that testing occurred.

Make worklists reflect actual readiness

A worklist should show which tests are ready, waiting, on hold, or assigned elsewhere. Define those states in laboratory terms. A received order may still lack the required specimen or information.

Then test priority changes and referral work. Staff should understand what moved, why, and who owns it. An item should not vanish from view simply because another department now handles it.

Also distinguish workflow progress from clinical urgency. Priority and escalation rules need laboratory leadership approval. Software should implement the agreed process rather than invent its own response.

Keep a visible queue for unresolved issues. Missing details, interface failures, and held results need named ownership. A dashboard count without a next action does little to move the work.

Analyzer interfaces need end-to-end tests

An interface may send orders to an analyzer and bring results back. Confirm the exact instrument, software version, message format, and supported workflow. “Analyzer integration” is too broad to serve as acceptance criteria.

Next, test units, flags, identifiers, and multi-part results. The receiving value must attach to the correct order and specimen. A successful connection does not prove a correct clinical mapping.

Also simulate repeats, duplicates, and late messages. The system needs a defined way to distinguish a repeated transmission from a new test run. Preserve relevant run history instead of overwriting blindly.

When an interface fails, staff need a readable error and safe recovery process. Retrying a message should not create an unintended second result or attach it to another record.

Result review and release need clear authority

A result entering the LIS does not necessarily mean it is ready to report. Define the review and release steps for each relevant workflow. The responsible laboratory team should own those rules.

For automated checks, document what the rule tests and what happens when it fails. Do not assume that a general automation setting is suitable for every discipline or result type.

Next, test manual review. A reviewer needs source context, relevant flags, and the right permissions. The system should record who released the result and when.

In the United States, CMS’s CLIA program information provides an official starting point for applicable laboratory requirements. A software product alone does not establish compliance with the lab’s obligations.

Reports and electronic results must preserve meaning

A report combines results with patient, order, specimen, and other relevant context. The electronic message should preserve the intended meaning, not just transfer a text value.

HL7’s FHIR DiagnosticReport specification describes one standard structure for diagnostic reports. The actual interface still needs agreed profiles, versions, codes, and local validation.

Next, inspect the result in the receiving EHR. Confirm the patient, test, status, units, and report presentation. A successful send response does not prove that the clinician sees the intended record.

Also test an amended report. The receiving workflow should distinguish a correction from a new unrelated result. Staff need to know whether the original remains visible and how the change reaches users.

Corrections need a traceable process

Laboratory records may need correction after entry or release. The system should preserve the original information and record the reason, author, time, and resulting status. The exact route should follow the approved procedure.

Do not allow an ordinary edit to erase a released result’s history. A corrected value can affect downstream users, so the workflow must include the relevant communication and acknowledgment steps.

Next, test a demographic correction separately from a result correction. They can have different consequences. The system should apply the right process to each.

Also inspect exports and printed reports. The correction status should remain clear outside the main screen. Otherwise, an old file may appear to be the current report.

A vendor demonstration scenario

Use fictional patients and approved sample data. Create an order with two tests and one specimen, then create an aliquot for part of the work. Confirm the identity links before proceeding.

First, receive the specimen with one missing required detail. The workflow should hold or route it according to the lab’s approved rule. Resolve the issue and preserve the decision.

Next, send an analyzer result twice. The system should recognize the repeated transmission and avoid an unintended duplicate. Then send a result with an unmapped code and inspect the error queue.

After review and release, amend one result through the approved route. Check the laboratory record, printed report, and EHR view. The amendment should remain traceable across all three.

Finally, simulate downtime and reconciliation. Staff should be able to account for orders and results captured during the interruption. This scenario tests the complete chain rather than isolated screens.

Downtime and recovery are core requirements

A laboratory needs an approved continuity process for unavailable systems or interfaces. The LIS should support that process and the later reconciliation. Do not leave downtime handling until after launch.

Define what staff can record offline or on controlled forms. Then agree how they will assign identifiers, preserve sequence, and enter the records later. The goal is a checked handoff back to the system.

Next, test restoration using a realistic interruption. Confirm which messages replay and which need manual review. A successful database restore does not prove that every external system agrees with it.

Keep recovery responsibilities clear across the lab, IT, and suppliers. Each team needs a way to confirm that its part is complete before normal operation resumes.

Access, retention, and support arrangements

Give staff the permissions their role requires. Test order entry, review, release, correction, export, and administration separately. A shared account can make it harder to trace significant actions.

Also review vendor support access and data hosting. Confirm the arrangements with the organization’s privacy and security teams. Logs, test environments, and exports can contain sensitive information too.

Next, agree retention and export requirements. The lab should know which records, reports, mappings, and histories remain available if it changes products. A list of current results alone may not preserve the full record.

Anomoz’s article on custom healthcare software development explains broader planning for clinical systems. Apply that discipline to every custom extension around the LIS.

Plan a phased implementation

Begin with a defined discipline, site, or workflow. Clean the catalog and identity mappings before moving large volumes of records. Then validate the new process with the responsible laboratory team.

Budget for interfaces, devices, labels, migration, training, testing, and ongoing support. Ask which instrument connections and report formats cost extra. Also confirm how updates affect validated workflows.

If administrative or customer communication workflows need a tailored layer, custom crm development may help connect those records. Keep clinical decisions and laboratory validation within the approved systems and responsibilities.

Finally, assign owners for catalog changes and interface errors after launch. A system remains reliable only when the lab can maintain its rules and resolve exceptions.

Define turnaround measures before using them to compare services. Order-to-report time and specimen-receipt-to-release time start at different points. Keep held, referred, or corrected work visible so a summary does not hide the cases that need review.

Choose a traceable order-to-result path

Good Laboratory information system software preserves identity, workflow, and review evidence across every handoff. Test the full chain with the laboratory team. Then expand from a validated pilot and clear operating ownership.